194 related articles for article (PubMed ID: 4579393)
1. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
[No Abstract] [Full Text] [Related]
2. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
Tsuang MM; Lu LM; Stotsky BA; Cole JO
J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
[No Abstract] [Full Text] [Related]
3. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
Gonier T; Schiele BC; Vestre ND
Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
[No Abstract] [Full Text] [Related]
4. Serum prolactin and clinical state during neuroleptic treatment and withdrawal.
Laughren TP; Brown WA; Williams BW
Am J Psychiatry; 1979 Jan; 136(1):108-10. PubMed ID: 758812
[No Abstract] [Full Text] [Related]
5. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
Steele C; Lucas MJ; Tune L
J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol and thioridazine in treatment of chronic schizophrenics.
Prasad L; Townley MC
Dis Nerv Syst; 1966 Nov; 27(11):722-6. PubMed ID: 5925664
[No Abstract] [Full Text] [Related]
7. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
Claghorn JL
Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
[No Abstract] [Full Text] [Related]
8. A double-blind comparison of haloperidol oral concentrate, haloperidol solutabs and placebo in the treatment of chronic schizophrenia.
Ota KY; Kurland AA
J Clin Pharmacol New Drugs; 1973; 13(2):99-110. PubMed ID: 4568299
[No Abstract] [Full Text] [Related]
9. Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
Cowley LM; Glen RS
J Clin Psychiatry; 1979 Oct; 40(10):411-9. PubMed ID: 489517
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol--new addition to the drug treatment of schizophrenia.
Stewart A; Lafave HG; Segovia G
Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
[No Abstract] [Full Text] [Related]
11. Thiothixene and thioridazine in anxiety.
Rickels K; Weise CC; Clark EL; Jenkins BW; Rose CK; Rosenfeld H; Gordon PE
Br J Psychiatry; 1974 Jul; 125(0):79-87. PubMed ID: 4605378
[No Abstract] [Full Text] [Related]
12. Double-blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients.
Lingl FA
Psychosomatics; 1973; 14(4):235-40. PubMed ID: 4604344
[No Abstract] [Full Text] [Related]
13. Clinical investigations and computer analysis of EEG effects of thioridazine hydrochloride on chronic schizophrenics.
Akpinar S; Itil T; Marasa J; Keskiner A
Psychiatr Clin (Basel); 1972; 5(5):289-99. PubMed ID: 4559602
[No Abstract] [Full Text] [Related]
14. Drug treatment in newly admitted schizophrenic patients.
Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
[No Abstract] [Full Text] [Related]
15. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
[TBL] [Abstract][Full Text] [Related]
16. Changes in cognition, attention and language in acute schizophrenia.
Blum RA; Livingston PB; Shader RI
Dis Nerv Syst; 1969 Jan; 30(1):31-6. PubMed ID: 5775757
[No Abstract] [Full Text] [Related]
17. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
[No Abstract] [Full Text] [Related]
18. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
[No Abstract] [Full Text] [Related]
19. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
Altman H; Mehta D; Evenson RC; Sletten IW
J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
[No Abstract] [Full Text] [Related]
20. High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.
Bjørndal N; Bjerre M; Gerlach J; Kristjansen P; Magelund G; Oestrich IH; Waehrens J
Psychopharmacology (Berl); 1980 Jan; 67(1):17-23. PubMed ID: 6768075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
